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Background: Independent external audits play an important role in quality assurance programme in radiation
oncology. The audit supported by the IAEA in Serbia was designed to review the whole chain of activities in 3D
conformal radiotherapy (3D-CRT) workflow, from patient data acquisition to treatment planning and dose delivery.
The audit was based on the IAEA recommendations and focused on dosimetry part of the treatment planning and
delivery processes.
Methods: The audit was conducted in three radiotherapy departments of Serbia. An anthropomorphic phantom
was scanned with a computed tomography unit (CT) and treatment plans for eight different test cases involving
various beam configurations suggested by the IAEA were prepared on local treatment planning systems (TPSs). The
phantom was irradiated following the treatment plans for these test cases and doses in specific points were
measured with an ionization chamber. The differences between the measured and calculated doses were reported.
Results: The measurements were conducted for different photon beam energies and TPS calculation algorithms.
The deviation between the measured and calculated values for all test cases made with advanced algorithms were
within the agreement criteria, while the larger deviations were observed for simpler algorithms. The number of
measurements with results outside the agreement criteria increased with the increase of the beam energy and
decreased with TPS calculation algorithm sophistication. Also, a few errors in the basic dosimetry data in TPS were
detected and corrected.
Conclusions: The audit helped the users to better understand the operational features and limitations of their TPSs
and resulted in increased confidence in dose calculation accuracy using TPSs. The audit results indicated the
shortcomings of simpler algorithms for the test cases performed and, therefore the transition to more advanced
algorithms is highly desirable.
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Quality Assurance (QA) in radiotherapy treatment plan-
ning process is essential to ensure that the dose calcula-
tion is performed correctly and to minimize the
likelihood of accidental exposure [1,2]. Many studies
have been performed that lead to the development of
guidelines and protocols for QA of 3D radiotherapy
TPSs [3,4]. Some studies have been done for solving spe-
cific problems associated with TPSs performance and* Correspondence: lakiruki@gmail.com
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reproduction in any medium, provided the ordose calculation [5-7]. For the purpose of acceptance
testing, commissioning and QA of TPSs, the IAEA has
published Technical Reports Series No. 430 [8] that pro-
vides the general framework and describes a large num-
ber of tests and procedures to be considered by the TPS
users. However, small hospitals with limited resources or
large hospitals with high patient load and limited staff
are not always able to perform all procedures recom-
mended in this report, therefore the IAEA prepared a
set of practical tests for dosimetry calculations in radio-
therapy, defined in a dedicated technical document,
TECDOC 1583 [9].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the dosimetric audit of TPSs in Serbia. The methodology
of this audit focuses on dosimetry part of the treatment
planning and delivery processes. An anthropomorphic
phantom is used with a set of clinical test cases prepared
by the IAEA, covering a range of typical clinical radi-
ation techniques in 3D CRT. The audit methodology
verifies the chain in external beam radiotherapy work-
flow, from patient data acquisition to treatment planning
and dose delivery.
Methods
The audit was conducted in three out of six radiotherapy
departments in Serbia, i.e. the Institute of Oncology of
Vojvodina in Sremska Kamenica, the Clinical Centre in
Niš and the Institute of Oncology and Radiology of
Serbia in Belgrade. Hospitals where audit was not con-
ducted either did not have computerized TPS or their
treatment machines were out of working order during
the auditing period. The audit programme required two
days per hospital to be carried out.
Phantom
The choice of the phantom for this study was based on
the following considerations: minimal restricted flexibil-
ity, easy handling and capability to perform all dosimet-
ric and anatomical test cases. From the comparison of
different phantoms for clinical commissioning of TPSs
following an IAEA protocol given in TECDOC 1583 [9],
it was chosen that the clinical test case measurements
will be conducted on the semi-anthropomorphic phan-
tom CIRS Thorax 002 LFC (CIRS Inc., Norfolk,
Virginia). The phantom is elliptical in shape (30 cm long
x 30 cm wide x 20 cm thick) and represents an average
human torso in proportion, density and two-dimensional
structure. The body of the phantom is made of plastic
water, lung and bone sections containing 10 holes to
hold interchangeable rod inserts for an ionization cham-
ber. The holes are numbered as shown in Figure 1. The
phantom was supplemented with a set of four reference
plugs with well-defined relative electron densities
(muscle, bone, lung and adipose equivalent tissue).
The phantom was scanned in each hospital using a
CT. Dose measurements were performed by placing the
calibrated ionization chamber into the different holes in
the phantom. The scanning procedure and that for the
dose measurements are described in the sections below.
CT calibration
The purpose of this test was to verify the Hounsfield
units (HU) to relative electron density (RED) conversion
curve stored in the TPSs. The phantom was scanned
twice in each hospital using a CT. For the first scan the
reference plugs with different known material propertieswere inserted into the holes in the phantom to check
CT numbers to the RED conversion curve. Recom-
mended arrangement of the reference plugs for the first
CT scan were: hole 2- muscle reference plug, hole 4 -
adipose reference plug, hole 5 - syringe filled with water,
hole 6 - lung reference plug, hole 7 - should be empty to
represent air and hole 10 - bone reference plug.
The second scan was done without reference plugs
and was used for the planning of clinical test cases as
defined in the TPS audit exercise. During second scan
all holes were filled with appropriate rod inserts. The
local scanning protocol was used, and the scanning para-
meters for both scans were kept the same. The accept-
ance criteria for the difference between the stored and
measured values of CT numbers for the same RED was
± 20HU [8].
Clinical test cases
A set of clinical test cases was created to verify a range
of basic treatment techniques applied in the clinical
practice. The beam geometry and sample dose distribu-
tion are shown in Figure 1. The detailed description of
test cases is given in the IAEA TECDOC 1583 [9]. The
measurement points for each case were selected to avoid
high dose gradients and measurements in the penumbra
region. The total number of measurement points in
eight test cases was fifteen. The same set of clinical test
cases was applied in all three hospitals. The dose calcu-
lations were performed for each available algorithm
based on the grid size normally used in the hospital’s
clinical practice.
Treatment planning systems
Two different calculation algorithms implemented
on three CMS XiO (Elekta CMS Software, St. Louis,
Missouri) versions 4.33, 4.40 and 4.60 TPSs were investi-
gated. All three hospitals use inhomogeneity corrections
in clinical practice. The full description of implemented
calculation algorithms are beyond the scope of this
paper and can be found elsewhere [10-13]. The algo-
rithms in this study have been divided into two groups:
Type (a) algorithms. Model based algorithms where
changes in lateral electron and photon transport are
not modeled (no lateral transport). Such algorithms use
a pencil beam convolution model and primarily
equivalent path length corrections to account for
inhomogeneities.
Type (b) algorithms. Model based algorithms where
changes in lateral electron and photon transport are
approximately modeled (with lateral transport). These
algorithms use a point kernel convolution/
superposition model and account for the density
variation in 3D.
Figure 1 Position of measurement points in CIRS thorax phantom and beam geometry, measurement points and sample dose
distribution for eight test cases.
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CT scanners used in the study were Somatom 4 Plus
(Siemens, Erlangen) and Light speed RT (General Elec-
tric Inc., Fairfield, Connecticut). Dose measurements
were performed in three hospitals using different linear
accelerators with nominal photon energies of 6 and 15
MV from the Varian Clinac 2100 series (Varian Medical
Systems, Palo Alto, California); 6 and 15 MV beams
from Siemens Oncor accelerators (Siemens Medical
Solutions, Erlangen) and 6 and 15 MV beams from
Elekta Synergy accelerators (Elekta Oncology Systems,
Crawley). The photon beams were divided according to
the energy into two groups: lower energy X-ray (6 MV)
and higher energy X-ray (15MV) beams. In two institu-
tions Farmer type chambers FC65-G (IBA Dosimetry,
Schwarzenbruck, Germany) were used while in one insti-
tution ionisation chamber NE 2571 (Nuclear Enterprise
Technology, U.K) was employed. In all measurements
Dose 1 (IBA Dosimetry, Schwarzenbruck, Germany) elec-
trometer was used. All chambers and the electrometer
were calibrated by the national secondary standards dos-
imetry laboratory. For all measurement points, the
absorbed dose to water was determined from ionization
chamber measurements using the IAEA TRS 398 dosim-
etry code of practice [14]. When measuring in lung and
bone equivalent materials it is assumed that the doses aremeasured in small water cavities within these materials.
Since these small cavities have not been outlined on CT
slices during dose calculations, the reported doses in these
materials have a larger uncertainty than those in plastic
water. The impact of water cavities has been estimated to
increase the calculated dose by up to 2% for lung equiva-
lent material and up to 0.3% for bone equivalent material
in worst case scenarios.
Analysis of the results
For the evaluation of the measured (Dmeas) and TPS calcu-
lated (Dcal) values the criteria specified in IAEA TRS 430
were employed. However, due to the limited number of
available positions for dose measurements in the phantom
and for better consistency in the interpretation of the
results for the various points the dose differences were
normalized to the dose measured at the reference point
for each test case, i.e. the following equation was used:
δ %ð Þ ¼ 100x Dcalc  Dmeasð Þ
Dmeas;ref
where Dmeas, ref is the dose value measured at the refer-
ence point. This reference point is a point that is expected
to have received 2 Gy, and it was specified for each test
case. For multiple beam combination the difference
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beam should be related to the dose measured at the refer-
ence point for the corresponded beam. The agreement cri-
teria for each test case were determined according to the
complexity of the test case geometry.Results
CT to RED conversion
All systems reviewed in this audit had generic or TPS
manufacturer supplied CT to RED conversion curves.
Based on the measurements, we concluded that there
were differences of 6-12% in the region of higher elec-
tron densities in two out of three cases (Figure 2). How-
ever, it was estimated that this difference in relative
electron density affects dose calculation accuracy less
than 2% [9,15]. In Figure 2 we also presented a zoom at
high density region with TPS data added.Clinical test cases
The differences between the measured and calculated
doses for the various measurement points and test cases
for all three hospitals are presented in Figures 3 and 4.
The results are grouped according to the energies and
the calculation algorithms implemented (with or without
lateral transport). Also the value of the agreement cri-
teria for each measurement point and their sum, for the
points where there are contributions from a several
beams coming from various directions, is shown as a
thick purple line.
The differences in the results between centres with
similar calculation algorithms could be partly attributed
to model beam fitting process and CMS XiO TPS limita-





















Figure 2 CT calibration curves measured with CIRS phantom at threeThe largest deviations were observed in the custo-
mised blocking test (test 5) in point 7, which was
located within the lung equivalent material, see Figure 3.
The differences up to 9% for lower energy beams and up
to 15% for higher energy beams were found for the type
(a) algorithms. For the type (b) algorithms (Figure 4) the
results for both groups of beam energies were within the
agreement criteria.
The irregular L-shaped field test (test 6) had three
measurement points: one in plastic water (point 3), one in
the lung equivalent material (point 7) and one in the bone
equivalent material (point 10). Large deviations up to 9%
for lower energy beams and up to 12% for higher energy
beams were observed in point 7 for the algorithms type
(a), as can be seen in Figure 3. Type (b) algorithms showed
results within the agreement criteria (Figure 4).
The four-field box test (test 4) had three measurement
points: one at the isocentre in plastic water (point 5), one
in the lung equivalent material on the central axis of lat-
eral beams (point 6) and one in the bone equivalent ma-
terial on the central axis of vertical beams (point 10).
The deviations outside agreement criteria were found for
points 6 (lung) and 10 (bone) for type (a) algorithms for
all energies (Figure 3). The differences up to 9% for lower
energy beams and up to 14.8% for higher energy beams
were found in point 6 (lung). The dose in point 10 (bone)
was underestimated by 6% for lower energy beams and
7.2% for higher energy beams. Type (b) algorithms
yielded results within the agreement criteria (Figure 4).
Before the audit, all three centers used algorithms type
(a) for dose calculation in treatment plans for all
patients. During the comparison of both algorithm types
in clinical cases the largest deviations were observed for


























































































































































Figure 3 Difference between measured and calculated point doses for each test case for model based algorithms - no lateral
transport. (a) 6 MV photon beams, (b) 15 MV photon beams.
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lated by algorithms type (a) may result in reduction of
PTV volume covered by 95% isodose by up to 18%. Due
to this problem, the change in clinical practice was
introduced after the audit in all three centers and all
dose calculations in the thorax region are performed
with type (b) algorithm.
Also, the verification of basic dosimetry data input
into TPS was done. After the review of the dosimetric
data entered into the local TPS, it was found that the
head scatter factors for a 15 MV photon beam in one of
the hospitals were not correct and new measurementswith a mini phantom were performed to correct this
problem. In another hospital, a mistake in a wedge factor
entry for a high energy beam and 15 degree hard wedge
was discovered for the field 15x15 cm2 and it was
corrected.
The TPS data review within this audit appeared to be
an excellent opportunity to spot any errors in the local
TPS data and correct them.
Discussion
An adjustment in CT numbers to the RED conversion





















































































































































Figure 4 Difference between measured and calculated point doses for each test case for model based algorithms with lateral
transport. (a) 6 MV photon beams, (b) 15 MV photon beams.
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differences of 6-12% were found in the region with dens-
ities above that for water. However, the magnitude of
the error in the calculated dose due to this difference
was estimated to be less than 2% for the 6 MV photon
beam passing through 5 cm thick material with the RED
of 1.5 [9,15]. Therefore, the adjustments were not car-
ried out.
Although the TPS algorithm testing was not the pur-
pose of the audit, several general conclusions could be
drawn. The systematic dose overestimation by up to 15%
for the type (a) calculation algorithms was recorded for
all measurement points located inside the lung equiva-
lent material. It was observed that the range of devia-
tions was related to the beam energy, i.e. larger
deviations were observed for the higher beam energy[16]. Doses inside the bone equivalent material were
underestimated by up to 7% for both 6 MV and 15 MV
beams for both algorithm types [17]. In general, the type
(a) algorithms are not adequate for dose calculations in
the presence of and inside low density inhomogeneities,
while the type (b) algorithms showed good results for all
test cases.
Accordingly, a comparison of calculation for different
clinical lung treatment plans was carried out. Patient
plans were calculated by both algorithms, but irradiated
according to the results of the advanced type (b) algo-
rithm. The overall treatment time calculated with algo-
rithm type (b), was 5–7% longer in comparison to the
calculation of algorithm type (a), and the coverage of
PTV, in terms of 95% isodose, was better (up to 18%).
That means that the plan calculated by the simpler
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delivered, in reality leading to the underdosage of the
target volume. This applies both to lower energy and
even more to higher energy beams.
Differences between doses calculated with algorithms
type (a) and (b) are primarily due to changes in electron
transport in the lungs, which is not adequately taken
into account by algorithms type (a). Many papers have
demonstrated that simplistic algorithms can overesti-
mate the dose at tumor lung boundary which may be
misleading clinically and even contra-indicated [18-21].
Following findings from the audit, and recommenda-
tions from the literature [11], the preferred beam energy
for planning the lung tumors, was moved from higher to
lower energies in most thorax cases in the audited
clinics. In some cases were used combinations of higher
and lower energy beams due to better dose distribution.
Transition to more advanced algorithms provides a
better consistency between the reported and actually
delivered doses, which opens opportunities for establish-
ing a more precise dose-volume relationship for tumours
and normal tissues [22].
The range of the dose deviations that occurred in this
audit exercise reflects the relative dosimetric accuracy of
the treatment planning process from CT scanning to the
dose delivery [23]. The accuracy of the dose calculation
algorithm is one of the main factors affecting the overall
uncertainty of the dose delivered to the patient, and it is
very important to perform various tests to better under-
stand the TPS limitations. The test cases presented
within this audit proved to be useful to verify the TPS
calculations with measurements and to estimate the
magnitude of algorithm limitations in situations close to
clinical settings, however, it should be understood that
the type and number of tests performed should depend
on the local practice of a particular institution.
The users of different TPSs may utilize the final results
of tests as a reference data for the ongoing periodic QA
checks. However, it is important to emphasize that the
final dose calculation results may be affected by different
factors, such as the dose calculation grid, inadequacies
in input data, the choice of phantom used, and others.
The ionization chamber dosimetry with a limited
number of points has some restrictions as the results
may depend on the selection of individual points. How-
ever, the end-to-end approach is considered adequate
for the evaluation of the overall quality of the dose cal-
culations and to explore the limitations of the TPS
[9,24]. Some aspects such as the penumbra widening in
low density materials at higher energy beams (test 1,
point 9) may be better explored using film dosimetry
but this was beyond the objectives of this study [23].
Another advantage of the TPS audit is that it can be
performed in a reasonable amount of time in hospitalswith high patient load and limited staff and enables the
user to have his/her work evaluated by an independent
peer reviewer.Conclusions
The methodology described in the IAEA TECDOC 1583
was used to perform TPS audits in three radiotherapy
centers of Serbia. A few discrepancies in basic dosimet-
ric data were discovered and corrected. The results also
indicated the shortcomings of type (a) treatment plan-
ning algorithms and, therefore the transition to more
advanced algorithms, type (b), was implemented [25]. In
addition, it was decided to consistently plan future lung
cancer treatments with lower energy photon beams for
which the TPS dose calculations are more accurate com-
pared to those for higher energy beams. The audit could
also help the users to appreciate the properties, qualities
and operational characteristics of treatment planning
systems and to better understand their limitations.
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